{"acute kidney injury": 2.64, "acute respiratory distress syndrome": 5.26, "agranulocytosis": 3.63, "anaemia": 2.09, "bone marrow failure": 7.92, "colitis": 2.5, "condition aggravated": 2.27, "cytomegalovirus chorioretinitis": 221.5, "cytomegalovirus colitis": 161.73, "cytomegalovirus infection": 71.22, "cytomegalovirus infection reactivation": 125.62, "cytomegalovirus viraemia": 192.53, "cytopenia": 20.58, "depressed level of consciousness": 2.04, "drug ineffective": 3.13, "drug reaction with eosinophilia and systemic symptoms": 2.89, "drug resistance": 95.77, "encephalitis cytomegalovirus": 461.05, "encephalopathy": 4.28, "graft versus host disease": 32.73, "granulocytopenia": 14.14, "haemophagocytic lymphohistiocytosis": 25.4, "hepatic enzyme increased": 2.15, "hepatic function abnormal": 3.95, "hypoxia": 2.74, "intentional product use issue": 6.2, "leukopenia": 13.92, "liver disorder": 2.54, "multiple organ dysfunction syndrome": 11.05, "myelosuppression": 10.66, "nephropathy toxic": 12.44, "neutropenia": 8.89, "neutrophil count decreased": 4.31, "neutrophil pelger-huet anomaly present": 957.49, "off label use": 4.72, "pancytopenia": 20.11, "pathogen resistance": 92.25, "platelet count decreased": 4.53, "pneumocystis jirovecii pneumonia": 16.36, "pneumonia": 2.05, "pneumonia cytomegaloviral": 135.23, "post transplant lymphoproliferative disorder": 34.5, "product use in unapproved indication": 10.11, "product use issue": 18.79, "pseudomonas infection": 15.85, "renal failure": 2.36, "renal impairment": 4.08, "respiratory failure": 7.41, "retinal detachment": 19.09, "sepsis": 4.94, "septic shock": 6.44, "thrombocytopenia": 7.13, "thrombotic microangiopathy": 17.0, "transplant rejection": 52.51, "treatment failure": 2.34, "viral load increased": 15.4, "viral mutation identified": 60.39, "white blood cell count decreased": 5.44}